Profiel
Jan Tadeusz Czernuszka is the founder of Oxtex Ltd.
which was founded in 2011, where he holds the title of Chief Technical Officer & Director.
Currently, he holds the position of Head-Biomaterials Group at the University of Oxford and Dean & Vice President at Trinity College (Oxford).
Dr. Czernuszka's education history includes a graduate degree from the University of Oxford, an undergraduate degree from Imperial College London, and a doctorate from the University of Cambridge.
Actieve functies van Jan Tadeusz Czernuszka
Bedrijven | Functie | Begin |
---|---|---|
Oxtex Ltd.
Oxtex Ltd. Medical SpecialtiesHealth Technology Oxtex Ltd. operates as an early-stage medical device company. It develops novel devices for soft tissue expansion. The firm's technology comprises implantable self-inflating tissue expanders available in sizes and shapes to suit the specific needs of the clinician and the patient. The company was founded by Jan Tadeusz Czernuszka and David Edward Jackson in May 2011 and is headquartered in Witney, the United Kingdom. | Oprichter | 01-05-2011 |
University of Oxford | Corporate Officer/Principal | - |
Trinity College (Oxford) | Corporate Officer/Principal | - |
Opleiding van Jan Tadeusz Czernuszka
University of Oxford | Graduate Degree |
Imperial College London | Undergraduate Degree |
University of Cambridge | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Oxtex Ltd.
Oxtex Ltd. Medical SpecialtiesHealth Technology Oxtex Ltd. operates as an early-stage medical device company. It develops novel devices for soft tissue expansion. The firm's technology comprises implantable self-inflating tissue expanders available in sizes and shapes to suit the specific needs of the clinician and the patient. The company was founded by Jan Tadeusz Czernuszka and David Edward Jackson in May 2011 and is headquartered in Witney, the United Kingdom. | Health Technology |